Dr. Slovin on the Role of Immunotherapy for Prostate Cancer – OncLive
OncLive |
Dr. Slovin on the Role of Immunotherapy for Prostate Cancer
OncLive The FDA approval of sipuleucel-T (Provenge) represented the first successful immunotherapy for a solid tumor that showed a survival benefit. All approaches that have been done subsequently are attempting to look at other ways of using the body's immune … |
